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abstract
IntroductIon Human donor organ shortages have led surgeons and scientists to explore the use of animals as alternative 
organ sources. Acute thrombovascular rejection (AVr) is the main hurdle in xenotransplantation. disparities in nucleotide  
metabolism in the vessels of different species may contribute significantly to the microvascular component of AVr.
MetHods We evaluated the extent of nucleotide metabolism mismatch in selected organs and endothelial cells of different 
mammals with particular focus on the changes in activity of ecto-5’-nucleotidase (e5’n) elicited by exposure of porcine hearts 
or endothelial cells to human blood (ex vivo) or human plasma (in vitro).
results e5’n activity in the rat heart was significantly higher than in other species. We noted a significant difference 
(p<0.001) in e5’n activity between human and pig endothelial cell lines. Initial pig aortic endothelial e5’n activity decreased 
in vitro after a three-hour exposure to human and porcine plasma while remaining constant in controls. ex vivo perfusion with 
fresh human blood for four hours resulted in a significant decrease of e5’n activity in both wild type and transgenic pig hearts 
overexpressing human decay accelerating factor (p<0.001).
conclusIons this study provides evidence that mismatches in basal mammalian metabolic pathways and humoral immunity 
interact in a xenogeneic environment. understanding the role of nucleotide metabolism and signalling in xenotransplantation 
may identify new targets for genetic modifications and may lead to the development of new therapies extending graft survival.
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Human organ failure is one of the main causes of death and 
disability.1 Transplantation remains the most effective treat-
ment approach but its application is limited by the severe 
shortage of human organ donors.2 Transplantation of ani-
mal organs is one possible solution to overcome this prob-
lem.3 However, destructive immune and thrombotic mecha-
nisms that are triggered following transplantation between 
species lead to the destruction of the transplanted organ and 
must still be addressed.3–5 Although fundamental biological 
processes are generally similar across closely related mam-
malian species, several immunological incompatibilities 
and key metabolic differences exist that may lead ultimately 
to xenograft rejection.
Vascularised xenotransplants are subject to hyperacute 
rejection reactions resulting in an immediate organ fail-
ure.6,7 In the setting of pig-to-primate xenotransplantation, 
preformed xenoreactive antibodies have been implicated as 
key elicitors of immunological responses leading to hypera-
cute rejection. These antibodies recognise and bind to the 
galactose-α-1,3-galactose epitope present on the surface of 
pig endothelial cells,8,9 which in turn leads to activation of 
the complement system and destruction of graft cells.
Consistent with this model, the first successful approach-
es to overcome hyperacute rejection were directed towards 
inhibition of the complement cascade by expression of hu-
man complement regulatory molecules such as the human 
decay accelerating factor (hDAF) on the surface of endothe-
lial cells from the donor organism.10–12 This strategy resulted 
in an unprecedented extension of organ survival from min-
utes to days or weeks in pig-to-primate transplants.13–16 More 
recently, increased attenuation of hyperacute rejection has 
been achieved using porcine α-1,3-galactosyltransferase 
knockouts, thereby preventing formation of the galactose-
α-1,3-galactose bond in polysaccharides present at the en-
dothelial cell surface of donor organs.17–19 Following these 
spectacular advancements in effectively reducing hypera-
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cute rejection, acute vascular rejection, causing xenograft 
destruction over a period of days to weeks, is now consid-
ered to be a major impediment.7,20
Particular interest has been drawn to nucleotide metab-
olism following the observation of remarkable differences 
between species such as a decrease in activity of ecto-5’- 
nucleotidase (E5’N) by one order of magnitude in pigs rela-
tive to humans. Comparison of pig and human concentra-
tions of nucleotide metabolites highlights other significant 
differences.21 Disparities in nucleotide metabolism between 
species may be important in the vascular component of 
acute humoural rejection22,23 and may be a major impedi-
ment to the application of xenotransplantation.24,25
Metabolic sequelae following humoural immune re-
sponses remain ill defined in transplantation. Nucleosides 
and their catabolites are known to inhibit activated mam-
malian immune cells although the extent to which these 
anti-inflammatory effects may be beneficial and have a 
potential implication for transplantation is unknown.26 Pu-
rine and pyrimidine precursors have crucial roles in deter-
mining nucleotide levels important for the maintenance of 
organ function, underscoring the need to understand the 
mechanisms of nucleoside metabolism and the implications 
in different animal models.
As the endothelium has been identified as the primary 
rejection target,4 we have focused on the importance of spe-
cific biochemical species’ differences in endothelial cells 
and their implications for acute vascular rejection in trans-
plantation. We have also established other processes that 
are grossly different between species.27,28 Here, we evaluate 
and highlight some of these differences in different organs 
and cell lines from different mammals that are pertinent 
experimental models in the context of xenotransplantation 
research. Identification of these differences may lead to im-
provements of protection of endothelium during xenotrans-
plantation or allotransplantation.
Methods
Reagents for enzyme analyses and high performance liquid 
chromatography (HPLC) grade reagents were obtained from 
Merck (Poole, UK). [8-14C]Adenosine was obtained from ICN 
Pharmaceuticals (Basingstoke, UK). All other reagents were 
purchased from Sigma (Gillingham, Dorset, UK).
rodents
Male Lewis rats (14–16 weeks old; 210–310g [260.4 ±7.57g], 
n=5; Charles River, Margate, UK) and male C57BL mice (12–
14 weeks old; 24–32g [28.4 ±3.43g], n=5; Charles River) were 
bled after isoflurane anaesthesia (0.05ml unheparinised, 
non-citrated plastic Eppendorf tubes (Stevenage, UK), 0.5ml 
1.3M perchloric acid). The tubes were placed immediate-
ly in liquid nitrogen. The chest cavities were opened and 
hearts dissected. The hearts were explanted, then rapidly 
freeze-clamped and stored in liquid nitrogen until analysis.
Pigs
Wild type pigs (n=6) and transgenic pigs (n=5, Sus scrofa) 
constitutively overexpressing hDAF served as cardiac xe-
nograft donors (male and female, age: 3–8 weeks, weight: 
6.1–11.7kg). Heart tissue punch biopsies (1g) were taken 
from the left and right ventricles. All biopsies were placed 
immediately into liquid nitrogen for analysis. Venous blood 
samples were placed in plastic, unheparinised, non-citrated 
Eppendorf tubes (2ml) and frozen immediately in liquid ni-
trogen. Wedge biopsies of kidneys were taken for enzyme 
analysis.
baboons
Adult olive baboons (Papio anubis; n=3) weighing 9.9–16.8kg, 
supplied by the Southwest Regional Primate Research Center 
(San Antonio, TX, US), served as heart recipients. Prior to 
receiving xenotransplants or any test regimen, punch tissue 
biopsies (1g) were taken in duplicate from the left ventricle of 
the anaesthetised animal and placed immediately into liquid 
nitrogen. Baboon tissue was harvested at the time of cardiac 
xenograft or per protocol death (unpublished data).
Humans
Whole human venous blood was collected from fasting do-
nors (n=5). Human heart tissue samples (n=3), unaccept-
able for human transplant, were taken from beating heart 
donors whose ejection fraction was >40% (assessed by tran-
soesophageal echocardiography). Right and left ventricu-
lar punch biopsies (in triplicate) were taken from the do-
nor hearts and snap frozen in liquid nitrogen. Additionally, 
wedge tissue biopsies were performed on human kidneys 
not used for transplant (n=3). The biopsies were treated as 
above and stored in liquid nitrogen.
Heart perfusion system
The perfusion system has been described previously29 and 
included the following components: a centrifugal pump 
(Medtronic, Watford, UK); a reservoir; a thermostatically con-
trolled blood oxygenator (outflow connected to aortic cannu-
la); a water jacketed heart compartment; a haemofilter; and 
a circulator maintaining the temperature at 37ºC. Wild type 
and transgenic pigs of either sex were anaesthetised and in-
tubated. The chest was opened, and the aorta cannulated and 
clamped. Hearts were infused with cold cardioplegic solution 
before removal and connection to the perfusion apparatus. 
The system was filled with freshly collected heparinised hu-
man blood pooled from three ABO matched donors. Initial 
flow was adjusted to a perfusion pressure of 60mmHg (and 
maintained for 4 hours at 0.4–0.6l/min). Biopsy specimens 
were collected at the beginning and at the end of perfusion 
and specimens stored immediately in liquid nitrogen.
culture of endothelial cells
Pig aortic endothelial cells (PAEC) were prepared as de-
scribed previously.30 Human umbilical vein endothelial 
cells, human aortic endothelial cells, PAEC and pig umbili-
cal vein endothelial cells were obtained and cultured as de-
scribed in detail previously.31
enzyme assays
The nucleotide metabolising enzymes were assayed in 
homogenates of heart biopsies collected before and at the 
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end of perfusion as described previously.32 Porcine and hu-
man endothelial cells homogenates for enzyme assay were 
prepared from confluent endothelial cells.32 Erythro-9-(2-
hydroxy-3-nonyl)adenine was used as an adenosine deami-
nase inhibitor. Each sample was analysed by reverse phase 
HPLC.33 Protein concentration was determined using the 
Bradford method.34 Activity of lactate dehydrogenase iso-
zymes was measured as described by Wilson et al.35
blood purine and pyrimidine precursor and catabolite 
concentrations
Venous whole blood samples (0.5–2ml) were taken from 
mice (n=5), rats (n=5), pigs (n=11), baboons (n=3) and hu-
mans (n=3). Venous blood samples were collected prior to 
administration of any immunosuppressive or anticoagula-
tion regimens. HPLC was used to evaluate levels of purines 
and pyrimidines as described previously.33
tissues homogenisation and enzymes analysis
Enzyme analysis in heart homogenates was performed as 
described in detail previously.32 The conversion of substrates 
into products was analysed by reverse phase HPLC. Protein 
content was determined by using the Bradford method.
exposure of endothelial cells to human and porcine 
plasma with and without complement inhibitor
Human and porcine blood was collected. Tubes were centri-
fuged immediately and the plasma was collected. One por-
tion was heat inactivated at 56ºC for one hour. PAEC grown 
to confluence were washed in serum-free M199 media and 
incubated in media with 50% fresh human plasma (NHP), 
50% heat inactivated human plasma (HHP) or 50% porcine 
plasma (PP). PAEC were incubated with human or porcine 
plasma for 0 or 180 minutes at 37ºC (0 minutes reflects that 
plasma was added to the cell homogenates and removed im-
mediately and analysed). In another set of experiments, hu-
man C1 esterase inhibitor (CSL Behring, Haywards Heath, 
UK) was incubated with porcine and human treated plasma 
groups for up to 180 minutes at concentrations of 4mg/ml 
and 8mg/ml (data not shown). No significant changes in 
activity from control groups were seen. E5’N and other en-
zymes of nucleotide metabolism were assessed in cell ho-
mogenates as indicated above.
statistical analysis
All values are presented as the mean ± standard error of 
the mean. In vitro cultured cells experiments were repeated 
4–6 times (in triplicate each time), each controlled individu-
ally. Comparison of measurements was performed using 
the paired Student’s t-test. Comparison between groups was 
performed using the unpaired Student’s t-test or one-way 
analysis of variance (ANOVA). For analysis of enzyme activ-
ity during ex vivo perfusion, a non-parametric Mann–Whit-
ney U test was used. Statistical significance (two-tailed) was 
defined as p<0.05.
results
species comparison of enzymes of nucleotide metabolism
E5’N activity in the rat heart was significantly higher than 
in the heart other species (p<0.005) as well as human and 
porcine kidneys. The rank order of E5’N activity was Rat > 
Baboon > Mouse > Human > Pig (p<0.05; Fig 1). A significant 
difference (p<0.001) was also noted in E5’N activity between 
human and pig endothelial cell lines (Fig 2).
Activity of other nucleotide metabolism enzymes across 
the different species and organs tested is shown in Table 
1. The highest adenosine deaminase activity was found in 
figure 1  Mean ecto-5’-nucleotidase (e5’n) activity in species 
and organs relevant to xenotransplantation. data adopted from 1.
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figure 2 Mean ecto-5’-nucleotidase (e5’n) activity in human 
and porcine equivalent lysed endothelial cell types
Hu = endothelial cells; Ha = human aortic endothelial cells; 
Pa = pig aortic endothelial cells; Pu = pig umbilical vein 
endothelial cells
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the baboon heart (Baboon heart > Rat heart > Pig heart > 
Human heart > Mouse heart). Adenosine monophosphate 
deaminase activity was significantly different between spe-
cies (Mouse > Rat > Human > Pig > Baboon; p<0.05) as was 
purine nucleotide phosphorylase and adenosine kinase ac-
tivity (Mouse > Rat > Human > Baboon > Pig; p<0.05).
species-specific precursors and metabolites of purines 
and pyrimidines
Table 2 presents the results from the analysis of basal lev-
els of nucleotide precursors and metabolites in the venous 
blood of different species. Notably, we found a higher base-
line uric acid concentration in the venous blood of humans 
compared with the venous blood of pigs, mice and baboons 
(p<0.05), with the latter displaying the lowest level. Other 
differences were noted as shown in Table 2.
Decreased e5’n activity on exposure to human plasma in 
vitro
The initial pig aortic endothelial E5’N activity (9.15 ±1.87nmol/
min/mg, 9.62 ±1.56nmol/min/mg and 9.10 ±1.40nmol/min/
mg protein in NHP, HHP and control PP groups respectively) 
showed significant decrease after a three-hour exposure to 
human and porcine plasmas (4.58 ±0.47nmol/min/mg and 
6.76 ±0.57nmol/min/mg protein in NHP and HHP groups 
respectively) while it remained constant at 9.62 ±0.88nmol/
min/mg protein in PP controls (Fig 3). Incubation with C1 
inhibitor added to NHP showed partial attenuation of 
decrease in E5’N activity, to the same level as in HHP. 
Separate experiments indicated that E5’N activity remained 
constant during three-hour incubation with Hanks’ balanced 
salt solution (results not shown).
Decreased e5’n activity on ex vivo exposure of human 
plasma to transgenic pig heart
E5’N activity in transgenic pig hearts overexpressing hDAF 
(8.54 ±2.10nmol/min/mg protein; n=5) was significantly high-
er than in the wild type pig hearts (6.60 ±0.33nmol/min/mg 
protein; n=6) at the start of perfusion with fresh human blood 
(p<0.01; Fig 4). Ex vivo perfusion of pig hearts with fresh hu-
man blood for four hours resulted in significant decrease 
of E5’N activity in both wild type (4.01 ±0.32nmol/min/mg 
protein) and transgenic pig hearts (4.52 ±0.52nmol/min/mg 
protein) (p<0.001). This decrease in E5’N activity occurred 
despite attenuation of immune, functional and structural 
changes typical of hyperacute rejection in transgenic hearts.
Discussion
In this study we have demonstrated that there are significant 
differences in nucleotide metabolite levels and enzymatic 
activity between species relevant to transplantation. These 
novel data may provide further insights into the metabolic 
sequelae of acute vascular rejection in xenotransplantation 
and allotransplantation rejection mechanisms.
Additionally, we have demonstrated a potential mecha-
nism of acute vascular rejection. This involves a reduction 
in the capacity of the endothelium to convert proinflam-
matory and proaggregatory extracellular nucleotides into 
adenosine due to a specific decrease in E5’N activity. The 
decrease in E5’N activity occurs rapidly following contact 
with human blood or plasma. Complement depletion (by 
heat inactivation) of human plasma or C1 inhibition par-
tially attenuated E5’N activity decrease, while overexpres-
sion of hDAF in transgenic hearts was ineffective. Although 
table 1 Mean adenosine deaminase (aDa), adenosine monophosphate deaminase (aMPD), purine nucleotide phosphorylase (PnP) 
and adenosine kinase (aK)
species Organs enzyme activity (nmol/min/mg/wet tissue)
aDa aMPD PnP aK
Human Heart 0.73 ±0.63 1.64 ±0.17 1.23 ±0.09 0.15 ±0.02
Human Kidney 0.43 ±0.07 1.42 ±0.11 3.52 ±0.48
Pig Heart 0.91 ±0.03 0.21 ±0.01 0.70 ±0.19 0.03 ±0.00
Pig Kidney 0.14 ±0.02 1.11 ±0.10 12.30 ±0.50
Baboon Heart 4.34 ±0.07 0.16 ±0.04 2.99 ±0.71 0.05 ±0.00
rat Heart 1.62 ±0.23 3.77 ±0.19 1.45 ±0.25 0.20 ±0.01
Mouse Heart 0.46 ±0.03 6.04 ±0.30 13.54 ±1.18 0.32 ±0.02
table 2 Mean basal uric acid, purine and pyrimidine metabolite concentrations in mammalian whole venous blood samples
species Metabolites (nmol/ml)
Hypoxanthine inosine adenine uridine cytidine uric acid
Human 0.95 ±0.08 0.10 ±0.10 0.07 ±0.02 3.80 ±0.30 0.49 ±0.01 290.00 ±16.00*
Baboon 4.00 ±0.43 0.04 ±0.00 0.23 ±0.03 7.96 ±0.68 0.06 ±0.01 0.49 ±0.20
Pig 17.70 ±1.50 6.45 ±1.42 3.95 ±0.14 1.41 ±0.13 – 15.0 ±1.90
Mouse 0.67 ±0.21 0.86 ±0.41 1.52 ±0.33 38.40 ±5.37 2.55 ±0.05 11.32 ±1.06
*p<0.05
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controls with autologous porcine blood were not performed, 
our previous experience with purine enzyme activity meas-
urements in a small animal perfusion system indicates that 
any non-specific effects are unlikely.36
conclusions
These results suggest that complement inhibition is not suffi-
cient to fully protect porcine organs from injury on exposure 
to human plasma and highlights a role of additional factors 
in the process. Understanding these changes in E5’N activity 
in allotransplant and xenotransplant settings may lead to a 
better mechanistic understanding of acute vascular rejection, 
thromboregulation and xenograft cytoprotection.37
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